Associated Papers
DICER1 Mutational Spectrum in Intracranial CNS-Neoplasias-A Review and a Report from the CNS-InterREST GPOH Study Center.
Manea S et al.
Cancers, 2025
40361440 (PubMed )
Supplement: cancers-17-01513-s001.zip › cancers-3488083-supplementary.xlsx › Blatt_1_-_Tabelle_1
Genomic characterization of DICER1-associated neoplasms uncovers molecular classes.
Kommoss FKF et al.
Nature Communications, 2023
36966138 (PubMed )
Supplement: 41467_2023_37092_MOESM6_ESM.xlsx › Tabelle1
DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
Apellaniz-Ruiz M et al.
Genes, Chromosomes & Cancer, 2021
DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2019
Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.
Bandapalli OR et al.
International Journal of Cancer, 2018
DICER1 Syndrome: DICER1 Mutations in Rare Cancers.
Robertson JC et al.
Cancers, 2018
Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.
Kuhlen M et al.
European Journal of Pediatrics, 2016
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model.
Brenneman M et al.
F1000research, 2015
Select a paper to view details